Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

BlackRock Enhanced Equity Dividend Trust upgraded to buy with 8% yield and 8.08% NAV discount

Analyst Insights
28 May 2026
Seeking Alpha
View Source
Bullish
pluang ai news

The BlackRock Enhanced Equity Dividend Trust (BDJ) has been upgraded to a buy rating following its recent price pullback. It offers an attractive 8% yield and trades at an 8.08% discount to its net asset value (NAV). BDJ employs an option writing strategy that supports high and sustainable income but limits capital gains, making it suitable for income-focused investors rather than those seeking growth. Its NAV has steadily increased, backed by strong dividend coverage with 2025 earnings projections supporting over two years of payouts. The trust is more tax-efficient in tax-advantaged accounts due to the ordinary income classification of most distributions but tends to underperform traditional dividend ETFs during bull markets.

More News

YieldMax to close and liquidate four ETFs by June 18, 2026, focusing on stronger funds.

YieldMax to close and liquidate four ETFs by June 18, 2026, focusing on stronger funds.

YieldMax announced it will close and liquidate four ETFs—ABNY, DISO, FEAT, and FIVY—by June 18, 2026, following a portfolio review. The decision aims to concentrate resources on ETFs with higher investor demand and better market traction. Trading for...

Company Fundamentals
Bearish
57 minutes ago
Canborsa launches beta of first perpetual DEX for tokenized real-world assets with up to 20x leverage.

Canborsa launches beta of first perpetual DEX for tokenized real-world assets with up to 20x leverage.

Canborsa has launched the beta version of its decentralized exchange (DEX) on the Canton Network, enabling non-custodial perpetual trading of tokenized real-world assets like stocks, gold, oil, and cryptocurrencies with up to 20x leverage. The platfo...

Others
Bullish
57 minutes ago
Oculis' Phase 3 trials for OCS-01 in diabetic macular edema fail primary vision improvement endpoint.

Oculis' Phase 3 trials for OCS-01 in diabetic macular edema fail primary vision improvement endpoint.

Oculis announced that its Phase 3 DIAMOND trials for OCS-01 eye drops in diabetic macular edema did not meet the primary endpoint of improved visual acuity after 52 weeks. However, the treatment showed significant and lasting reduction in retinal thi...

Company Fundamentals
Bearish
2 hours ago
Allied Gold receives key regulatory approvals, extends deal deadline with Zijin Gold to July 29, 2026.

Allied Gold receives key regulatory approvals, extends deal deadline with Zijin Gold to July 29, 2026.

Allied Gold Corporation announced that Zijin Gold has received approval under the Investment Canada Act for its proposed acquisition of Allied Gold. This approval completes the Canadian regulatory process for the transaction. The deal has also cleare...

Company Fundamentals
Bullish
2 hours ago
Kentucky First Federal Bancorp may resume quarterly dividends up to $0.10 per share after a special board meeting on July 28, 2026.

Kentucky First Federal Bancorp may resume quarterly dividends up to $0.10 per share after a special board meeting on July 28, 2026.

Kentucky First Federal Bancorp announced a special board meeting on July 28, 2026, to consider resuming quarterly dividends on its common stock, potentially up to $0.10 per share. The company has suspended dividends since November 2023, and no final ...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App